214 related articles for article (PubMed ID: 10722660)
1. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase.
Flory E; Kunz M; Scheller C; Jassoy C; Stauber R; Rapp UR; Ludwig S
J Biol Chem; 2000 Mar; 275(12):8307-14. PubMed ID: 10722660
[TBL] [Abstract][Full Text] [Related]
2. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins: role of IkappaB kinase (IKK).
Amici C; Belardo G; Rozera C; Bernasconi D; Santoro MG
AIDS; 2004 Jun; 18(9):1271-80. PubMed ID: 15362659
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases.
Bossis G; Salinas S; Cartier C; Devaux C; Briant L
FEBS Lett; 2002 Apr; 516(1-3):257-64. PubMed ID: 11959143
[TBL] [Abstract][Full Text] [Related]
5. Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes.
Flory E; Weber CK; Chen P; Hoffmeyer A; Jassoy C; Rapp UR
J Virol; 1998 Apr; 72(4):2788-94. PubMed ID: 9525598
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat.
Sun Q; Matta H; Chaudhary PM
Retrovirology; 2005 Feb; 2():9. PubMed ID: 15713234
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
8. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB.
Yang X; Chen Y; Gabuzda D
J Biol Chem; 1999 Sep; 274(39):27981-8. PubMed ID: 10488148
[TBL] [Abstract][Full Text] [Related]
9. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.
Flory E; Hoffmeyer A; Smola U; Rapp UR; Bruder JT
J Virol; 1996 Apr; 70(4):2260-8. PubMed ID: 8642652
[TBL] [Abstract][Full Text] [Related]
10. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.
O'Mahony AM; Montano M; Van Beneden K; Chen LF; Greene WC
J Biol Chem; 2004 Apr; 279(18):18137-45. PubMed ID: 14963024
[TBL] [Abstract][Full Text] [Related]
11. Secretion of extracellular factor(s) induced by X-irradiation activates the HIV type 1 long terminal repeat through its kappaB motif.
Faure E; Rameil P; Lecine P; Rey F; Sire J; Kahn-Perles B; Imbert J
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):353-65. PubMed ID: 9519897
[TBL] [Abstract][Full Text] [Related]
12. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 Up-regulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappaB-dependent and -independent signaling pathways.
Dumais N; Barbeau B; Olivier M; Tremblay MJ
J Biol Chem; 1998 Oct; 273(42):27306-14. PubMed ID: 9765256
[TBL] [Abstract][Full Text] [Related]
14. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
15. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
Madrid LV; Mayo MW; Reuther JY; Baldwin AS
J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor kappa B: a potential target for anti-HIV chemotherapy.
Pande V; Ramos MJ
Curr Med Chem; 2003 Aug; 10(16):1603-15. PubMed ID: 12871131
[TBL] [Abstract][Full Text] [Related]
17. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
Mallardo M; Dragonetti E; Baldassarre F; Ambrosino C; Scala G; Quinto I
J Biol Chem; 1996 Aug; 271(34):20820-7. PubMed ID: 8702837
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity.
Li JM; Shen X; Hu PP; Wang XF
Mol Cell Biol; 1998 Jan; 18(1):110-21. PubMed ID: 9418859
[TBL] [Abstract][Full Text] [Related]
19. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.
Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A
J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
